Clinical Trials Directory

Trials / Unknown

UnknownNCT02699775

Effect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke Patients

Effect of 3 Consecutives Botulinum Toxin Injection on Gait Pattern in Stroke Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Centre d'Investigation Clinique et Technologique 805 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chronic stroke patients exhibit gait pattern alterations which are mainly due to spasticity and treated with repetitive multifocal botulinum toxin injection(BTI). Several studies demonstrated that single BTI-session in a single muscle of paretic lower limb(LL) improved kinematic gait parameters(GP) but surprisingly none of them assessed the effects of repetitive multifocal BTI on patient's gait pattern and their duration. The aim was to evaluate the impact of repetitive multifocal BTI-sessions on GP of chronic stroke patients. To that end, gait of patients will be compared using 3D-gait analysis after 3 consecutives BTI sessions.

Detailed description

All the patients will be treated with BTI . These injections will be performed under electrical stimulation control (\~5mA). The dose, the number of site of injection per muscle is at the discretion of the physician according to patients' needs and physicians' routine clinical practice. The dilution the most commonly used will be 100 U for 2.5ml (XEOMIN®)

Conditions

Interventions

TypeNameDescription
OTHERMotion AnalysisMotion analysis is used to assess the modifications of gait pattern in chronic spastic stroke patients regularly treated with botulinum toxin injection

Timeline

Start date
2017-12-12
Primary completion
2019-10-01
Completion
2019-12-01
First posted
2016-03-04
Last updated
2018-01-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02699775. Inclusion in this directory is not an endorsement.